Hangzhou Heshun TechnologyLTD Valuation
Is 301237 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 301237 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 301237 (CN¥21.96) is trading above our estimate of fair value (CN¥4.85)
Significantly Below Fair Value: 301237 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 301237?
Other financial metrics that can be useful for relative valuation.
| What is 301237's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | CN¥1.76b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 3x |
| Enterprise Value/EBITDA | 42.6x |
| PEG Ratio | 2.6x |
Price to Sales Ratio vs Peers
How does 301237's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2.9x | ||
300321 Shandong Tongda Island New MaterialsLtd | 5.8x | n/a | CN¥2.0b |
002002 Hongda Xingye | 0.6x | n/a | CN¥1.8b |
300920 Zhejiang Runyang New Material Technology | 4.1x | n/a | CN¥1.6b |
000635 Ningxia Yinglite Chemicals | 1.2x | n/a | CN¥2.1b |
301237 Hangzhou Heshun TechnologyLTD | 3.9x | 31.5% | CN¥1.8b |
Price-To-Sales vs Peers: 301237 is expensive based on its Price-To-Sales Ratio (3.9x) compared to the peer average (2.9x).
Price to Earnings Ratio vs Industry
How does 301237's PE Ratio compare vs other companies in the CN Chemicals Industry?
Price-To-Sales vs Industry: 301237 is expensive based on its Price-To-Sales Ratio (3.9x) compared to the CN Chemicals industry average (2.1x).
Price to Sales Ratio vs Fair Ratio
What is 301237's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 3.9x |
| Fair PS Ratio | 1.5x |
Price-To-Sales vs Fair Ratio: 301237 is expensive based on its Price-To-Sales Ratio (3.9x) compared to the estimated Fair Price-To-Sales Ratio (1.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.